Baculovirus expression, purification and evaluation of recombinant pneumococcal surface adhesin A of Streptococcus pneumoniae

Pathobiology

Volumn 67, Issue 3, 1999, Pages 115-122

  De, B K ^b,c   Sampson, J S ^a   Ades, E W ^a   Johnson, S E ^a   Stinson, A R ^a   Crook, J ^a   Tharpe, J A ^a   Huebner, R C ^b   Carlone, G M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Pasteur Merieux Connaught   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Baculovirus; Recombinant pneumococcal surface adhesin A; Staphylococcus pneumoniae

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; DNA FRAGMENT; MONOCLONAL ANTIBODY; OCTOXINOL; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BACTEREMIA; BACULOVIRUS; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOBLOTTING; IMMUNOGENICITY; LEPIDOPTERA; MOLECULAR CLONING; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL PROTEINS; BACULOVIRIDAE; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE; CLONING, MOLECULAR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; IMMUNIZATION; LIPOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; PNEUMOCOCCAL INFECTIONS; RECOMBINANT FUSION PROTEINS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032972394     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028060     Document Type: Article

References (38)

1. Dixon JMS: National Advisory Committee on Immunization. Pneumococcal Vaccine; in Canadian Immunization Guide, ed 3. Ministry of Supplies and Services, 1989, Cat No H49-8/ 1989E, pp 85-88.
2. Lee CJ, Wang TR: Pneumococcal infection and immunization in children. Crit Rev Microbiol 1994;20:1-12.
3. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M: Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992;268:3323-3327.
4. Dagan R, Englehard D, Piccard E, and the Israeli Pediatric Bacteremia and Meningitis Group: Epidemiology of invasive childhood pneumococcal infections in Israel. JAMA 1992;268:3328-3332.
5. Kuikka A, Syrjanen J, Renkonen OV, Valtonen V: Pneumococcal bacteremia during a recent decade. J. Infect 1992;24:157-168.
6. Afessa B, Greaves WL, Frederick WR: Pneumococcal bacteremia in adults: A 14-year experience in an inner-city university hospital. Clin Infect Dis 1995;21:345-351.
7. Advisory Committee on Immunization Practices, Prevention of Pneumococcal Diseases: Recommendations of the Advisory Committee on Immunization Practices. Morbid Mortal Weekly Rep 1997;46(RR8).
8. Butler JC, Breiman RF, Campbell JP, Lipman HB, Broome CV, Facklam RR: Polysaccharide pneumococcal vaccine efficacy. JAMA 1993; 270:1826-1831.
9. Makela PH, Sibakov M, Herva E, Henricksen J: Pneumococcal vaccine and otitis media. Lancet 1980;ii:547-551.
10. Kajhty H, Eskola J: New vaccines for the prevention of pneumococcal infections. Emerg Infect Dis 1996;2:289-298.
11. Eby R: Pneumococcal conjugate vaccines. Pharm Biotechnol 1995;6:695-718.
12. Robbins JB, Schneerson R: Polysaccharide-protein conjugates: A new generation of vaccines. J Infect Dis 1990;161:821-832.
13. Alexander JE, Lock RA, Peeters CC, Poolman JT, Andrew PW, Mitchell TJ, Hansman D, Paton JC: Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 1994;62: 5683-5688.
14. Kuo J, Douglas M, Ree KH, Lindberg AA: Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines. Infect Immun 1995;63:2706-2713.
15. Tart RC, McDaniel LS, Ralph BA, Briles DE: Truncated Streptococcus pneumoniae PsaA molecules elicit cross-protective immunity against pneumococcal challenge in mice. J Infect Dis 1996;173:380-386.
16. Briles DE, King JD, Gray MA, McDaniel LS, Swiatlo E, Benton KA: PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice. Vaccine 1996; 14:858-867.
17. Yamamoto M, McDaniel LS, Kawabata K, Briles DE, Jackson RJ, McGhee JR, Kiyono H: Oral immunization with PspA elicits protective immunity against Streptococcus pneumoniae infection. Infect Immun 1997;65:640-644.
18. Wu HY, Nahm MH, Guo Y, Russell MW, and Briles DW: Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis 1997;175:839-846.
19. Russell H, Tharpe JA, Wells DE, White EH, Johnson JE: Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae. J Clin Microbiol 1990;28:2191-2195.
20. Sampson JS, O'Connor SP, Stinson AR, Tharpe JA, Russell H: Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. Adhesins. Infect Immun 1994;62:319-324.
21. Talkington DF, Brown BG, Tharpe JA, Koenig A, Russell H: Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA). Microb Pathog 1996;21:17-22.
22. Tharpe JA, Russell H: Purification and seroreactivity of pneumococcal surface adhesin A (PsaA). Clin Diagn Lab Immunol 1996;3:227-229.
23. Sampson JS, Furlow Z, Whitney AM, Williams D, Facklam R, Carlone GM: Limited diversity of Streptococcus pneumoniae PsaA among pneumococcal vaccine serotypes. Infect Immun 1997;65:1967-1971.
24. Crook J, Tharpe JA, Johnson SE, Williams DB, Stinson AR, Facklam RR, Ades EW, Carlone GM, Sampson JS: Immunoreactivity of five monoclonal antibodies against the 37-kilodalton common cell wall protein (PsaA) of Streptococcus pneumoniae. Clin Diagn Lab Immunol 1998;5:205-210.
25. Tharpe JA, Russell H, Leinonen M, Plikaytis BD, Breiman RF, Carlone GM, Ades EW, Sampson JS: Comparison of a pneumococcal common protein (PsaA) antibody ELISA and a PsaA immune complex ELISA for detection of pneumococcal serum antibody. Pathobiology 1998;66:77-83.
26. King LA, Possee RD: The Baculovirus Expression System: A Laboratory Guide. London, Campman & Hall, 1992.
27. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
28. Wallich R, Simon MM, Hofmann HM, Moter SE, Schaible UE, Kramer MD: Molecular and immunological characterization of a novel polymorphic lipoprotein of Borrelia burgdorferi. Infect Immun 1993;61:4158-4166.
29. Marston BJ, Plouffe JF, File TM, Hackman BA, Salstrom S, Lipman HP, Kolczak MS, Brieman RB: Incidence of community-acquired pneumonia requiring hospitalization, Results of a population based active surveillance study in Ohio. Arch Intern Med 1997; 157:1709-1718.
30. Wu HC, Tokunaga M: Biogenesis of lipoproteins in bacteria. Curr Top Microbiol Immunol 1986;125:127-157.
31. Erdile LF, Brandt M, Warakomski DJ, Westrack GJ, Sadziene A, Barbour AG, Mays JP: Role of attached lipid in immunogenicity of Borrelia burgdorferi ospA. Infect Immun 1993; 61:81-90.
32. Hink WF, Thomsen DR, Davidson DJ, Meyer AL, Castellino FJ: Expression of three recombinant proteins using baculovirus vectors in 23 insect cell lines. Biotech Prog 1991;7:9-14.
33. Wickham TJ, Nemerow GR: Optimization of growth methods and recombinant protein production in BTI Tn-5B-4 insect cells using the baculovirus expression vector. Biotech Prog 1993;9:25-30.
34. Williams MD, Fieno AM, Grant RA, Sherman DH: Expression and analysis of a bacterial poly(hydroxy-alkanoate) synthetase in insect cells using a baculovirus system. Protein Expr Purif 1996;7:203-211.
35. Coulton JW, Chin AC, Vachon V: Recombinant porin in Haemophilus influenzae type b. J Infect Dis 1992:165(suppl 1):S188-191.
36. Charles I, Rodgers B, Musgrave S, Peakman TC, Chubb A, Fairweather N, Dougan G, Roberts M: Expression of P.69/pertactin from Bordetella pertussis in a baculovirus/insect cell expression system: Protective properties of the recombinant protein. Res Microbiol 1993;144: 681-690.
37. Charles IG, Rodgers BC, Makoff AJ, Chatfield SN, Slater DE, Fairweather, NF: Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system. Infect Immun 1991;59:1627-1632.
38. Allet B, Bernard AR, Hochmann A, Rohrbach E, Graber P, Magnenat E, Mazzei GJ, Benasconi L: A bacterial signal peptide directs efficient secretion of eukaryotic proteins in the baculovirus expression system. Protein Expr Purif 1997;9:61-68.